COVID-19 and aging: Identifying measures of severity

Maria Teresa Neves1, Leonor Vasconcelos de Matos1, Ana Carolina Vasques1

  • 1Department of Medical Oncology Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal.

SAGE Open Medicine
|July 12, 2021
PubMed

Insights

Older adults with COVID-19 experienced more complications and higher mortality. Specific severity scores are crucial for this population to ensure optimal care and identify mortality predictors like elevated C-reactive protein.

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • COVID-19 disproportionately affects older adults, necessitating a comparison of clinical features and mortality predictors between age groups.
  • Understanding age-specific clinical presentations and outcomes is vital for effective patient management.

Purpose of the Study:

  • To compare clinical characteristics of older COVID-19 patients (≥65 years) with younger and middle-aged individuals.
  • To identify independent predictors of in-hospital mortality in elderly COVID-19 patients.

Main Methods:

  • Retrospective analysis of 195 patients hospitalized with COVID-19 from March to June 2020.
  • Comparison of clinical data, laboratory values, and outcomes between older and younger age groups.
  • Statistical analysis to determine independent predictors of mortality.

Main Results:

  • Older adults (56.9%) exhibited higher rates of multimorbidity and more frequent complications.
  • Elevated admission scores (Early Warning Score-2, Modified Early Warning Score) and inflammatory markers (C-reactive protein, D-dimer) were observed in the older group.
  • Modified Early Warning Score and C-reactive protein >5 mg/dL were independent predictors of in-hospital mortality in older patients.

Conclusions:

  • Older COVID-19 patients face increased risks of complications and mortality.
  • Developing and utilizing age-specific severity scores is essential for providing optimal care to elderly individuals.
  • Early identification of high-risk older patients can guide timely interventions and improve outcomes.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
53
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
52
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
99
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
539
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.7K